3/18
03:10 pm
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
Low
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
3/5
08:14 am
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
Low
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
2/14
01:16 pm
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $6.00 price target on the stock.
Medium
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $6.00 price target on the stock.
2/14
01:16 pm
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $6.00 price target on the stock.
Medium
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $6.00 price target on the stock.